International E-publication: Publish Projects, Dissertation, Theses, Books, Souvenir, Conference Proceeding with ISBN.  International E-Bulletin: Information/News regarding: Academics and Research

ER-α, HMGA2 and Wnt5a Correlates with the Grade of Mammary Phyllodes Tumor

Author Affiliations

  • 1Departement of Anatomical Pathology, Faculty of Medicine, Jambi University, Jambi, Indonesia
  • 2Departement of Obstetrics and Gynecology, Faculty of Medicine, Padjadjaran University, Bandung, West Java, Indonesia
  • 3Departement of Anatomical Pathology, Faculty of Medicine, Padjadjaran University, Bandung, West Java, Indonesia
  • 4Departement of Clinical Pathology, Faculty of Medicine, Padjadjaran University, Bandung, West Java, Indonesia

Int. Res. J. Medical Sci., Volume 4, Issue (6), Pages 1-6, June,28 (2016)

Abstract

stromal overgrowth and double-layered epithelial component arranged in clefts which in combination elaborate leaf-like structures. Unlike epithelial neoplasm of the duct and gland of the breast, there were inconsistencies of pathogenesis and unestablished indications for hormonal therapy of PT. The aim of this study is to analysis the immunoexpression of hormonal receptors (ER-&

References

  1. Tan P. H. (2012)., Fibroepithelial Tumours., WHO Classification of Tumours of the Breast.
  2. Tse G.M., Niu Y. and Shi H.J. (2010)., Phyllodes tumor of the breast: an update., Breast cancer, 17(1), 29-34.
  3. Mishra S.P., Tiwary S.K., Mishra M. and Khanna A.K. (2013)., Phyllodes Tumor of Breast: A Review Article., Surgery, 2013, 1-10.
  4. Tan P.H. and Ellis I.O. (2013)., Myoepithelial and epithelial-myoepithelial, mesenchymal and fibroepithelial breast lesions: updates from the WHO Classification of Tumours of the Breast 2012., Journal of clinical pathology, 66(6), 465-70.
  5. Tse G.M., Lee C.S. and Kung F.Y. (2002)., Hormonal receptors expression in epithelial cells of mammary phyllodes tumors correlates with pathologic grade of the tumour., Am J Clin Pathol, 118, 522- 526.
  6. Jara-Lazaro A.R. and Tan P.H. (2009)., Molecular pathogenesis of progression and recurrence in breast phyllodes tumors., American Journal of Translational Research, 1(1), 23-34.
  7. Sawyer EJ HA, Rowan AJ, Gillett CE and Thomas RE, Poulsom R et al. (2002)., The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours., J Pathol, 196, 437-44.
  8. Sawyer E.J., Hanby A.M., Poulsom R., Jeffery R., Gillett C.E. and Ellis I.O., et al. (2003)., Beta-catenin abnormalities and associated insulin-like growth factor overexpression are important in phyllodes tumours and fibroadenomas of the breast., The Journal of pathology, 200(5), 627-32.
  9. Pfannkuche K., Summer H., Li O., Hescheler J. and Droge P. (2009)., The high mobility group protein HMGA2: a co-regulator of chromatin structure and pluripotency in stem cells., Stem cell reviews, 5(3), 224-30.
  10. Ben Hassouna J., Damak T., Gamoudi A., Chargui R., Khomsi F. and Mahjoub S. et al. (2006)., Phyllodes tumors of the breast: a case series of 106 patients., American journal of surgery, 192(2), 141-7.
  11. Nurhayati H.M., Siti-Aishah A., Reena Z. and Rohaizak M. (2014)., Ko-pengekspresan Reseptor Estrogen beta (ERβ) dan Aktin Otot Licin pada Tumor Filodes di Payudara: Suatu Kajian Tisu Mikroarai., Sains Malaysiana, 43(2), 8.
  12. Sapino A., Bosco M., Cassoni P., Castellano I., Arisio R. and Cserni G. et al. (2006)., Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast., Modern pathology: an official journal of the United States and Canadian Academy of Pathology, 19(4), 599-606.
  13. Ilić I., Ranđelović P., Ilić R., Katić V., Milentijević M. and Veličković L., et al. (2009)., An approach to malignant mammary phyllodes tumors detection., Vojnosanitetski pregled, 66(4), 277-82.
  14. Kim Y.H., Kim G.E., Lee J.S., Lee J.H., Nam J.H. and Choi C., et al. (2012)., Hormone receptors expression in phyllodes tumors of the breast., Analytical and quantitative cytology and histology/the International Academy of Cytology [and] American Society of Cytology, 34(1), 41-8.
  15. Tse G.M.K., Lee C.S., Kung F.Y.L., Scolyer R.A., Law B.K.B. and Lau T-s et al. (2002)., Hormonal Receptors Expression in Epithelial Cells of Mammary Phyllodes Tumors Correlates With Pathologic Grade of the Tumor., A Multicenter Study of 143 Cases, 118(4), 522-6.
  16. Bouris P., Skandalis S.S., Piperigkou Z., Afratis N., Karamanou K. and Aletras A.J. et al. (2015)., Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells., Matrix biology: journal of the International Society for Matrix Biology, 43, 42-60.
  17. Guttilla I.K., Adams B.D. and White B.A. (2012)., ERalpha, microRNAs, and the epithelial-mesenchymal transition in breast cancer., Trends in endocrinology and metabolism, 23(2), 73-82.
  18. Lin J.J., Huang C.S., Yu J., Liao G.S., Lien H.C. and Hung J.T., et al. (2014)., Malignant phyllodes tumors display mesenchymal stem cell features and aldehyde dehydrogenase/disialoganglioside identify their tumor stem cells., Breast cancer research,1 6(2), R29.
  19. Pfannkuche K., Summer H., Li O., Hescheler J. and Droge P. (2009)., The high mobility group protein HMGA2: a co-regulator of chromatin structure and pluripotency in stem cells., Stem cell reviews, 5(3), 224-30.
  20. Singh I., Mehta A., Contreras A., Boettger T. and Carraro G., Wheeler M. et al. (2014)., Hmga2 is required for canonical WNT signaling during lung development., BMC biology, 12, 21.
  21. Henriksen J., Stabell M., Meza-Zepeda L.A., Lauvrak S.A., Kassem M. and Myklebost O. (2010)., Identification of target genes for wild type and truncated HMGA2 in mesenchymal stem-like cells., BMC Cancer, 10, 329
  22. Dreux N., Marty M., Chibon F., Velasco V. and Hostein I., Ranchere-Vince D., et al. (2010)., Value and limitation of immunohistochemical expression of HMGA2 in mesenchymal tumors: about a series of 1052 cases., Modern pathology: an official journal of the United States and Canadian Academy of Pathology, 23(12), 1657-66.
  23. Wang X, Liu X, Li AY, ChenL, LaiL and LinHH, et al. (2011)., Overexpression of HMGA2 promotes metastasis and impacts survival of colorectal cancers., Clin Cancer Res, 17 (8):257080.
  24. Hristov A.C., Cope L., Reyes M.D., Singh M., Iacobuzio-Donahue C. and Maitra A., et al. (2009)., HMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma., Mod Pathol, 22(1), 439.
  25. Karim R.Z., Gerega S.K., Yang Y.H., Horvath L., Spillane A. and Carmalt H. et al. (2009)., Proteins from the Wnt pathway are involved in the pathogenesis and progression of mammary phyllodes tumours., Journal of clinical pathology, 62(11), 1016-20.
  26. Sawyer E.J., Hanby A.M., Rowan A.J., Gillett C.E., Thomas R.E. and Poulsom R., et al. (2002)., The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours., The Journal of pathology,196(4):437-44.
  27. Creighton C.J., Chang J.C. and Rosen J.M. (2010)., Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer., Journal of mammary gland biology and neoplasia, 15(2), 253-60.
  28. Yook J.I., Li X.Y., Ota I., Fearon E.R., Weiss S.J. (2005)., Wnt-dependent regulation of the E-cadherin repressor snail., J Biol Chem, 280(12), 11740-8.
  29. Bo H., Zhang S., Gao L., Chen Y., Zhang J. and Chang X. et al. (2013)., Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells., BMC Cancer,13, 496.
  30. Saitoh T., Mine T. and Katoh M. (2002)., Frequent up-regulation of WNT5A mRNA in primary gastric cancer., Int J Mol Med, 9(5), 515-519.
  31. Weeraratna A.T., Jiang Y., Hostetter G., Rosenblatt K., Duray P., Bittner M. and Trent J.M. (2002)., Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma., Cancer Cell, 1(3), 279288.
  32. Holcombe R.F., Marsh J.L., Waterman M.L., Lin F., Milovanovic T. and Truong T. (2002)., Expression of Wnt ligands and Frizzled receptors in colonic mucosa and in colon carcinoma., Mol Path, 55(4), 220-226.